Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Company dossier
Fredun Pharmaceuticals
BSE:FREDUN · ISIN INE194R01017
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Fredun Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Fredun Pharmaceuticals Ltd - 539730 - Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Issue Of Bonus Equity Shares.BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Fredun Pharmaceuticals Ltd - 539730 - Notice Convening 39Th Annual General Meeting ('AGM') Of Fredun Pharmaceuticals LimitedBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM).BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26BSE · corporate action · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Revised Outcome.BSE · financial results · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May, 2026BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Audited Results For The Quarter And Year Ended On 31St March, 2026.BSE · financial results · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · corporate action · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Monitoring Agency ReportBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for The Meeting To Be Held On Monday, 25 May, 2026.BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 09Th April, 2026BSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Conversion of SecuritiesBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing